The board of directors of China Resources Phoenix Healthcare Holdings Company Limited announced the changes of the directors, the chief executive officer of the company, the chief financial officer of the company, composition of the remuneration committee of the company and the nomination committee of the company and the authorized representative of the company pursuant to Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited with effect from October 12, 2017. Mr. He Xuan has resigned as a non-executive director due to other business commitments. Mr. Liang Hongze has resigned as a non-executive director and a member of the nomination committee due to other business commitments.

Mr. Wu Potao has resigned as an executive director, the chief executive officer, a member of the remuneration committee and an authorized representative as he will serve as the general manager of China Resources Healthcare Group Limited. Mr. Xu Zechang has resigned as an executive director due to other business commitments and will remain as the executive general manager and director of healthcare of the company. Mr. Li Zhiyue has resigned as the chief financial officer due to other business commitments.

Mr. Han Yuewei has been appointed as an executive director, the chief executive officer, a member of the remuneration committee and an authorized representative. Mr. Han Yuewei worked for China Resources Land Limited since October 2010 before joining the Group, during which he served as deputy general manager of Shenyang Region, deputy general manager of Shenzhen Region, director of engineering and vice president. Ms. Ren Yuan has been appointed as an executive director and the chief financial officer.

From February 2004 to February 2010, Ms. Ren served as the finance director of Wuxi CR Micro-Assemb Tech. Ltd. Prior to joining the Group, Ms. Ren worked as the consultancy director and deputy general director of the information management department of China Resources (Holdings) Co. Ltd. since February 2010.

Ms. Fu Yanjun has been appointed as an executive Director. Ms. Fu Yanjun joined the Group in December 2014 and has been appointed as the deputy general manager of the company since November 2016. Ms. Fu also previously served as the managing director of strategic investment department of the company, the chairman of the board and the general manager of Beijing Wanrong Yikang Pharmaceutical Company Limited and Beijing Phoenix Jiayi Medical Equipment Company Limited and the executive chairman and the chairman of the youth committee of the Group.

Mr. Cheng Libing, an executive director and the vice chairman of the board, has been appointed as a member of the nomination committee.